Angio Consult GmbH

🎙️ Join Us at MedTech Malta! 🌍 We’re thrilled that Benjamin Joas Rieck will be speaking at MedTech Malta this year! He will share insights on the journey of cardiovascular medical devices from concept to care. 🚀 MedTech World also recently featured AngioConsult in an article that dives deep into how we support MedTech innovators in overcoming regulatory hurdles and achieving market success. Check out the full story here: https://lnkd.in/etAeZcsj 📖 Don’t miss Benjamin’s session and the chance to connect with us in Malta—together, we’re paving the way for groundbreaking MedTech advancements! 💡 #AngioConsult #MedTechMalta #HealthcareInnovation #MarketEntry #RegulatorySuccess #MedTechConference MedTech World

👏 News from #VIVA2024! 👏   We’re thrilled to see Endologix LLC present the 3-year results of the DETOUR2 Study at the VIVA Late-Breaking Clinical Trial Session, led by Dr. Sean Lyden. This milestone underscores the impact of innovation and collaboration in advancing solutions for patients with complex vascular conditions.   A huge congratulations to the whole Endologix LLC team on this achievement! Together, we’re pushing the boundaries of what’s possible in peripheral vascular intervention. 💪 #AngioConsult #Endologix #VIVA2024 #DETOUR2 #ClinicalTrials #InnovationInHealth

🚀 Only 2 days to go until #MedTechMalta2024, and we couldn’t be more grateful to our incredible sponsors who make this event possible! The day we’ve all been waiting for is almost here, and we’re excited to welcome leaders, innovators, and changemakers from across the globe. This event isn’t just a conference; it’s a vibrant space where connections spark, ideas ignite, and opportunities emerge. 👏 A huge thank you to each of our partners for your support and dedication to advancing the MedTech industry. Your commitment allows us to bring together pioneering minds for a truly impactful experience. lifespin GmbH, Zapyrus, BrightHills, Prismatic Softwares Private Limited, Rapid Nexus Nanotech Wound Solutions, Inc. FormlyAI, Malta Digital Innovation Authority, AIVHY LTD, Romeo Life Sciences Consulting, Specculo, Prolucid Technologies, Check4Cancer, GT LifeScience, Malta Medicines Authority, KSI Group, Primary Health Care, Inc (PHC), Angio Consult GmbH, St Vincent de Paul, Malta Enterprise, Lifeblood, National Mental Health Services for Malta, University of Malta, Labena Ventures, MedTech Impact Partners, Goodwin, ACCELLERATE LIMITED, Swift Sync, ADTEC TECHNOLOGY, INC. OstomySecure, Stand Speak Rise Up!, Kemtai, Digiclap, FINN Partners, The Wales Malta Initiative, OxiWear, THE NATIONAL ALLIANCE FOR RARE DISEASES SUPPORT MALTA, Curistica, Malta Venture Capital - MVC, Houston Methodist, Velox Solutions, Mater Dei Hospital - Malta, Carecircle, Enable Health, Caresyntax. We’re adding the final touches and eagerly anticipating an unforgettable experience here in #Malta. Here’s to sparking innovation and moving MedTech forward—together! ✔️Stay updated on all the exciting happenings at MedTech Malta across all our media platforms! https://lnkd.in/dFgZ2Tuh

Register today for our November 15th webinar,  “Acute Coronary Syndrome long-term outcomes: raising the bar” from 12-1pm CET (6-7am EST). 🫀Stephan Achenbach and Mirvat Alasnag will moderate this case-based discussion. We’ll be joined by a panel of experts using #DynamX:   - Stefan James, will present the latest INFINITY-SWEDEHEART RCT clinical data for patients with acute coronary syndrome. 83% (significant) reduction in TLF in patients with Acute Coronary Syndrome was demonstrated by INFINITY SWEDEHEART RCT presented at #TCT2024  - Hee Hwa Ho will discuss singaporean experience with the primary PCI study - Dr. Tak Shun Chung and Dr. Michał Hawranek will present their cases with #DynamX 👉Register now: https://lnkd.in/exnX423s *DynamX is CE marked. Not for sale in the U.S. #MedTech #Innovation PMN 2038 Rev A

🚨 We're nominated for the MedTech World Awards! Vote for us today!🚨 Dear partners, supporters, and friends, We’re thrilled to share that we’re in the running for the MedTech World Awards in the "MedTech Service Provider Excellence Award of the Year" category, and we need your support! Please take a moment to vote for us by tomorrow, November 4th 🗳️🙌 Klick here to vote 🔗 : https://lnkd.in/eUfra5V6 🌍 This week, we’re also gearing up to attend Med Tech Malta, where we'll be sharing insights in a keynote session. We’re looking forward to connecting, learning, and being inspired by the incredible innovation across the industry! 👉 Your vote would mean the world to us – thank you for standing by our side on this journey! Let’s keep pushing the boundaries of what’s possible in med tech. See you in Malta! 🇲🇹 #MedTechWorld #MedTechMalta #AngioConsult #VoteNow #Innovation #Teamwork

🌟 Presenting at #TCT2024! 🎤 Yesterday, Benjamin Joas Rieck showcased the innovative GrOwnValve technology at the Innovation Theater. His talk outlined a one-stop-shop platform for creating patient-specific transcatheter heart valve prostheses for children and adults. 🫀 This cutting-edge approach has the potential to transform care for both children and adults, emphasizing our commitment to innovation in cardiovascular treatments. A massive shoutout and thank you to all who attended and supported! 👏 #TCT2024 #GrOwnValve #CardiovascularInnovation #AngioConsult 🚀

📊NEW DATA: INFINITY-SWEDEHEART RCT 12-month outcomes comparing #DynamX®* with a contemporary DES in patients with acute coronary syndrome and complex lesion subsets after six months. ➡️ Landmark analysis (6-12 months) showed DynamX bioadaptor significantly reduces adverse events compared to DES, confirming unique mechanism of action after unlocking at 6 months ➡️ Clinical results in patients with ACS demonstrated 83% reduction (0.3% vs. 1.8%; (p<0.018)) in TLF rate ➡️ Clinical results in patients with lesions in the LAD vessels demonstrated 73% reduction (0.2% vs. 2.2%) in TLF rate ➡️ There were no TLF events in patients with small vessels (less than or equal to 2.75 mm) in the DynamX arm Learn more about the results: https://lnkd.in/etMwb9XZ INFINITY-SWEDEHEART data were published concurrently in The Lancet: https://lnkd.in/etYST6ap *CE marked. Not for sale in the U.S. #Cardiovascular #Medtech #Innovation #TCT2024 PMN 2032 REV A

🌟 Starting the day right at #TCT2024! 🌟 We’re live at #TCT2024 in Washington, D.C., ready to dive into exciting days of innovation and learning. Don’t miss out on Benjamin Rieck's insightful presentation! 📍Catch us at the Innovation Theater on Monday at 11:00 AM to hear about "A Living Endogenous Patient-Specific TAVR System (GrOwnValve)." Let’s shape the future of cardiac care together! 🚀 #AngioConsult #Cardiology #Innovation #TCT2024

🚀 Big News from AngioConsult! 🚀 We're excited to announce that Benjamin Joas Rieck is set to take the stage at #TCT2024 in Washington, D.C.! Catch his session on "A Living Endogenous Patient-Specific TAVR System (GrOwnValve)" on Monday, October 28th at 11:00 AM in the Innovation Theater. This is your chance to dive into the future of cardiovascular technology with a presentation that promises to be as insightful as it is revolutionary. 📅 Save the date! Come connect with us and explore groundbreaking advancements in cardiology. #TCT2024 #TCT #AngioConsult #HealthTech #Innovation #Cardiology #TAVR

🚀 Next stop: #TCT2024 in Washington, DC! 🌐 Get ready to connect with us at one of the most anticipated cardiology events of the year. We're thrilled to share insights, learn from industry leaders, and showcase how AngioConsult is pushing the boundaries in cardiovascular care. 🫀 📍 Join us to discover the latest advancements and collaborate on future innovations. Let’s shape the future of cardiology together! #TCT #Cardiology #AngioConsult #HealthcareInnovation #WashingtonDC